BG62172B1 - Съединения и продукти на реакцията на amaдори, метод затяхното производство и използването им - Google Patents

Съединения и продукти на реакцията на amaдори, метод затяхното производство и използването им Download PDF

Info

Publication number
BG62172B1
BG62172B1 BG98956A BG9895694A BG62172B1 BG 62172 B1 BG62172 B1 BG 62172B1 BG 98956 A BG98956 A BG 98956A BG 9895694 A BG9895694 A BG 9895694A BG 62172 B1 BG62172 B1 BG 62172B1
Authority
BG
Bulgaria
Prior art keywords
reaction
radical
molecular weight
amadori
glucose
Prior art date
Application number
BG98956A
Other languages
Bulgarian (bg)
English (en)
Other versions
BG98956A (bg
Inventor
Jan Z. Mioduszewski
Krystyna Witkiewicz
Anna Inglot
Original Assignee
Torf Establishment
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Priority claimed from PL29346492A external-priority patent/PL171023B1/pl
Application filed by Torf Establishment filed Critical Torf Establishment
Publication of BG98956A publication Critical patent/BG98956A/bg
Publication of BG62172B1 publication Critical patent/BG62172B1/bg

Links

Classifications

    • C—CHEMISTRY; METALLURGY
    • C08—ORGANIC MACROMOLECULAR COMPOUNDS; THEIR PREPARATION OR CHEMICAL WORKING-UP; COMPOSITIONS BASED THEREON
    • C08B—POLYSACCHARIDES; DERIVATIVES THEREOF
    • C08B37/00—Preparation of polysaccharides not provided for in groups C08B1/00 - C08B35/00; Derivatives thereof
    • C08B37/0006—Homoglycans, i.e. polysaccharides having a main chain consisting of one single sugar, e.g. colominic acid
    • C08B37/0009—Homoglycans, i.e. polysaccharides having a main chain consisting of one single sugar, e.g. colominic acid alpha-D-Glucans, e.g. polydextrose, alternan, glycogen; (alpha-1,4)(alpha-1,6)-D-Glucans; (alpha-1,3)(alpha-1,4)-D-Glucans, e.g. isolichenan or nigeran; (alpha-1,4)-D-Glucans; (alpha-1,3)-D-Glucans, e.g. pseudonigeran; Derivatives thereof
    • C08B37/0021—Dextran, i.e. (alpha-1,4)-D-glucan; Derivatives thereof, e.g. Sephadex, i.e. crosslinked dextran
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K8/00—Cosmetics or similar toiletry preparations
    • A61K8/18—Cosmetics or similar toiletry preparations characterised by the composition
    • A61K8/30—Cosmetics or similar toiletry preparations characterised by the composition containing organic compounds
    • A61K8/60—Sugars; Derivatives thereof
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K8/00—Cosmetics or similar toiletry preparations
    • A61K8/18—Cosmetics or similar toiletry preparations characterised by the composition
    • A61K8/30—Cosmetics or similar toiletry preparations characterised by the composition containing organic compounds
    • A61K8/64—Proteins; Peptides; Derivatives or degradation products thereof
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P37/00—Drugs for immunological or allergic disorders
    • A61P37/02—Immunomodulators
    • A61P37/06—Immunosuppressants, e.g. drugs for graft rejection
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61Q—SPECIFIC USE OF COSMETICS OR SIMILAR TOILETRY PREPARATIONS
    • A61Q19/00—Preparations for care of the skin
    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07H—SUGARS; DERIVATIVES THEREOF; NUCLEOSIDES; NUCLEOTIDES; NUCLEIC ACIDS
    • C07H7/00—Compounds containing non-saccharide radicals linked to saccharide radicals by a carbon-to-carbon bond
    • C07H7/02—Acyclic radicals
    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07K—PEPTIDES
    • C07K9/00—Peptides having up to 20 amino acids, containing saccharide radicals and having a fully defined sequence; Derivatives thereof
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K38/00—Medicinal preparations containing peptides
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61Q—SPECIFIC USE OF COSMETICS OR SIMILAR TOILETRY PREPARATIONS
    • A61Q5/00—Preparations for care of the hair

Landscapes

  • Health & Medical Sciences (AREA)
  • Chemical & Material Sciences (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • General Health & Medical Sciences (AREA)
  • Organic Chemistry (AREA)
  • Animal Behavior & Ethology (AREA)
  • Public Health (AREA)
  • Veterinary Medicine (AREA)
  • Engineering & Computer Science (AREA)
  • Biochemistry (AREA)
  • Molecular Biology (AREA)
  • Medicinal Chemistry (AREA)
  • Epidemiology (AREA)
  • Genetics & Genomics (AREA)
  • Birds (AREA)
  • Immunology (AREA)
  • Chemical Kinetics & Catalysis (AREA)
  • Biotechnology (AREA)
  • Bioinformatics & Cheminformatics (AREA)
  • Dermatology (AREA)
  • Proteomics, Peptides & Aminoacids (AREA)
  • Biophysics (AREA)
  • Materials Engineering (AREA)
  • Polymers & Plastics (AREA)
  • General Chemical & Material Sciences (AREA)
  • Transplantation (AREA)
  • Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
  • Pharmacology & Pharmacy (AREA)
  • Peptides Or Proteins (AREA)
  • Medicines That Contain Protein Lipid Enzymes And Other Medicines (AREA)
  • Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
  • Steroid Compounds (AREA)
  • Organic Low-Molecular-Weight Compounds And Preparation Thereof (AREA)
  • Preparation Of Compounds By Using Micro-Organisms (AREA)
  • Cephalosporin Compounds (AREA)
  • Saccharide Compounds (AREA)
  • Cosmetics (AREA)
  • Medicines Containing Plant Substances (AREA)
BG98956A 1992-02-13 1994-08-05 Съединения и продукти на реакцията на amaдори, метод затяхното производство и използването им BG62172B1 (bg)

Applications Claiming Priority (3)

Application Number Priority Date Filing Date Title
PL29346492A PL171023B1 (pl) 1992-02-13 1992-02-13 Sposób wytwarzania nowych induktorów cytokin
EP92103614 1992-03-03
PCT/EP1993/000327 WO1993016087A2 (en) 1992-02-13 1993-02-11 Amadori reaction compounds and products, process for their manufacture, and their use

Publications (2)

Publication Number Publication Date
BG98956A BG98956A (bg) 1995-07-28
BG62172B1 true BG62172B1 (bg) 1999-04-30

Family

ID=26130822

Family Applications (1)

Application Number Title Priority Date Filing Date
BG98956A BG62172B1 (bg) 1992-02-13 1994-08-05 Съединения и продукти на реакцията на amaдори, метод затяхното производство и използването им

Country Status (20)

Country Link
US (1) US5723504A (cs)
JP (1) JPH07506344A (cs)
AT (1) ATE187734T1 (cs)
AU (1) AU672595B2 (cs)
BG (1) BG62172B1 (cs)
BR (1) BR9305878A (cs)
CA (1) CA2130106A1 (cs)
CZ (1) CZ285200B6 (cs)
DE (2) DE69327310D1 (cs)
ES (1) ES2072244T1 (cs)
GR (1) GR950300017T1 (cs)
HU (1) HUT70434A (cs)
MX (1) MX9300759A (cs)
NO (1) NO304026B1 (cs)
RO (1) RO115633B1 (cs)
RU (1) RU2141337C1 (cs)
SG (1) SG52390A1 (cs)
SK (1) SK86994A3 (cs)
TW (1) TW302368B (cs)
WO (1) WO1993016087A2 (cs)

Families Citing this family (10)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US5629412A (en) * 1994-07-11 1997-05-13 Glinskii; Guennadi V. Synthetic glycoamines that promote or inhibit cell adhesion
FR2746316B1 (fr) * 1996-03-19 1998-06-12 Guerlain Nouvelles compositions cosmetologiques ou dermatologiques
AU3511297A (en) * 1996-06-27 1998-01-14 Picower Institute For Medical Research, The 3-alkylamino-2-hydroxy-4-hydroxymethyl-2-cyclopenten-1-one advanced glycosylation endproducts and methods of use therefor
DE19705233A1 (de) * 1997-02-12 1998-08-13 Froelich Juergen C Verfahren zur Herstellung einer Formulierung enthaltend Arginin
GB0319463D0 (en) * 2003-08-20 2003-09-17 Givaudan Sa Compounds
TW200925268A (en) * 2007-12-06 2009-06-16 Mallinckrodt Baker Inc Fluoride-containing photoresist stripper or residue removing cleaning compositions containing conjugate oligomeric or polymeric material of alpha-hydroxycarbonyl compound/amine or ammonia reaction
JP2012140360A (ja) * 2010-12-28 2012-07-26 Kracie Home Products Ltd 抗酸化剤、化粧料、飲食品組成物及び医薬品組成物
JP2012140377A (ja) * 2010-12-29 2012-07-26 Kracie Home Products Ltd チロシナーゼ活性阻害剤、メラニン産生抑制剤及び美白剤、並びにこれらを含有する化粧料、飲食品組成物及び医薬品組成物
JP5835894B2 (ja) * 2010-12-29 2015-12-24 クラシエホームプロダクツ株式会社 チロシナーゼ活性阻害剤、メラニン産生抑制剤及び美白剤、並びにこれらを含有する化粧料、飲食品組成物及び医薬品組成物
JP2012140378A (ja) * 2010-12-29 2012-07-26 Kracie Home Products Ltd チロシナーゼ活性阻害剤、メラニン産生抑制剤及び美白剤、並びにこれらを含有する化粧料、飲食品組成物及び医薬品組成物

Family Cites Families (8)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
CA673730A (en) * 1963-11-05 K. Jacobi Otto Method of preparing a synthetic moisturizing material
GB1514910A (en) * 1974-07-02 1978-06-21 Unilever Ltd Amadori compounds and their use to flavour foods
LU83711A1 (fr) * 1981-10-23 1983-06-07 Oreal Compositions huileuses comprenant un principe actif dermatologique,destinees au traitement du cuir chevelu ou de la peau
US4629692A (en) * 1982-12-06 1986-12-16 Miles Laboratories, Inc. Immunoassay for nonenzymatically glucosylated proteins and protein fragments an index of glycemia
DE3405841A1 (de) * 1984-02-17 1985-08-22 Bayer Ag, 5090 Leverkusen N-acylierte 1-alkylamino-1-desoxy-ketose-derivate, verfahren zur herstellung und ihre verwendung
DE3601472A1 (de) * 1986-01-20 1987-07-23 Fresenius Ag Verwendung von umsetzungsprodukten von reduzierenden zuckern und serotonin oder serotonin-precursoren zur behandlung cerebraler stoerungen
GB2218102B (en) * 1988-04-08 1992-09-16 Sandoz Ltd Calcitonin peptide derivatives
EP0533865B1 (en) * 1991-03-16 1998-01-14 Torf Establishment Peat-derived bioactive products and pharmaceutical and cosmetic compositions containing them

Also Published As

Publication number Publication date
NO304026B1 (no) 1998-10-12
SG52390A1 (en) 1998-09-28
HU9402347D0 (en) 1994-10-28
ATE187734T1 (de) 2000-01-15
WO1993016087A2 (en) 1993-08-19
CA2130106A1 (en) 1993-08-14
HUT70434A (en) 1995-10-30
TW302368B (cs) 1997-04-11
AU672595B2 (en) 1996-10-10
DE69327310D1 (de) 2000-01-20
US5723504A (en) 1998-03-03
BG98956A (bg) 1995-07-28
NO942930D0 (no) 1994-08-08
MX9300759A (es) 1993-11-01
CZ285200B6 (cs) 1999-06-16
BR9305878A (pt) 1997-08-19
JPH07506344A (ja) 1995-07-13
AU3496693A (en) 1993-09-03
CZ194594A3 (en) 1994-12-15
RU2141337C1 (ru) 1999-11-20
SK86994A3 (en) 1995-02-08
RO115633B1 (ro) 2000-04-28
GR950300017T1 (en) 1995-04-30
DE632813T1 (de) 1996-02-15
RU94040167A (ru) 1996-07-10
WO1993016087A3 (en) 1993-09-16
ES2072244T1 (es) 1995-07-16
NO942930L (no) 1994-08-08

Similar Documents

Publication Publication Date Title
Gao et al. Sturgeon protein-derived peptides exert anti-inflammatory effects in LPS-stimulated RAW264. 7 macrophages via the MAPK pathway
CZ287816B6 (en) Peptide, process of its preparation, pharmaceutical preparation in which it is comprised and use thereof
BG62172B1 (bg) Съединения и продукти на реакцията на amaдори, метод затяхното производство и използването им
US5114926A (en) Tetrapeptide inhibiting the entry into cycle of hemopoietic stem cells processes for its preparation, and its uses
RU2136695C1 (ru) Сывороточный гликопротеин, обладающий биологической активностью в сверхмалых дозах
SU638243A3 (ru) Способ очистки гамма- -глутамилтаурина
US4046877A (en) Method of increasing immunologic competence
EP0654272A1 (en) Alimentary canal cell activator
US6469137B1 (en) Myelopeptides and their therapeutic use
RU2110275C1 (ru) Способ получения пептида, обладающего анаболической активностью, стимулирующего увеличение массы тела, развитие эпидермального слоя и роста волосяного покрова
EP0632813B1 (en) Amadori reaction compounds and products, process for their manufacture, and their use
JPS6388200A (ja) 胸腺抽出物、その製造方法及びそれを含む薬剤組成物
JPS5959654A (ja) ホルモン放出因子類似体及びその製造方法
CA1056305A (en) Protein having thymus hormone-like activity
CA1322715C (en) Use of a tripeptide and composition thereof as an immunostimulating agent
US6458761B2 (en) Synthetic, statistic thymic peptide combination and its use as a preparation with immunological and/or endocrinological effect
RU2097432C1 (ru) Гликопротеин tcf-ii и фармацевтическая композиция, содержащая эффективное количество гликопротеина tcf-ii
CN1075969A (zh) 阿马多瑞反应化合物及产物，其生产方法和用途
PL171023B1 (pl) Sposób wytwarzania nowych induktorów cytokin
WO1997003653A1 (en) Enterogenin pharmaceutical form
RU2121480C1 (ru) Пептид, обладающий влиянием на регенерацию кроветворной и иммунной систем, и фармацевтическая композиция на его основе
JP2000514839A (ja) 合成及び統計学的な胸腺ペプチドの化合物、及び、免疫学及び／又は内分泌学的効果を発揮する製剤としての用途
JPH07138287A (ja) 新規なペプチドおよび免疫賦活剤
JPS5858340B2 (ja) Ｎ↓−ε↓−トリメチル↓−Ｌ↓−リジン塩
JPH02215730A (ja) 細胞増殖抑制剤